This TRAN1 award helped to fund the development of Siren Biotechnology’s lead therapy, SRN-101, for high-grade glioma brain cancers in patients. In this reporting period, we completed the final ...

UC Davis scientists win $7 million in California stem cell research grants ...

Tissue-selective chemoattractants direct lymphocytes to epithelial surfaces to establish local immune environments, regulate immune responses to food antigens and commensal organisms, and protect from ...

3. Update on contracts and interagency agreements. 4. Update on grants management system. 5. Consideration of amendment to agreement with Kutir Corporation. 7. Consideration ofproposal to fund any ...

Tremendous progress has been made in identifying genetic variants associated with neurodevelopmental disorders (NDDs), particularly autism spectrum disorder (ASD). However, the extensive (and growing) ...

The development of the cerebral cortex is a stepwise process that involves numerous cell types and signaling pathways to achieve the functional assembly of neural circuits. Our understanding of this ...

Leukocyte Adhesion Deficiency-I (LAD-I) BLA submitted to FDA for RP-L201. Based on the positive efficacy and safety data from the pivotal study of RP-L201, Rocket submitted the BLA to the FDA, as its ...

Glioblastoma (GBM) is the deadliest form of primary brain tumor with limited treatment options. Recent studies have profiled GBM tumor heterogeneity, revealing numerous axes of variation that explain ...

Stem Cell Agency Grants Working Group Meeting MEETING OF THE SCIENTIFIC AND MEDICAL RESEARCH FUNDING WORKING GROUP (GRANTS REVIEW WORKING GROUP) OF THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE ...

Alpha thalassemia (AT) is an inherited blood disorder caused by mutations in HBA2/1 genes encoding for α-globin chain, which together with β-globin chain constitutes the hemoglobin protein complex, ...

Our proposal was to generate patient IPSC organoids from several neurodevelopmental diseases and assess these ‘diseases in a dish’ for preclinical response to ASOs to correct disease-associated ...

San Diego stem cell scientists awarded $8.7M to research cancer, other diseases ...